Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Read now
António M.F. Araújo, Jose C. Mendez, Ana L. Coelho, Berta Sousa, Fernando Barata, Ana Figueiredo, Teresina Amaro, Isabel Azevedo & Marta Soares. (2009) Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer. Cancer Investigation 27:4, pages 391-396.
Read now
Read now
Articles from other publishers (9)
Bayan A. Rahal & Sanaa K. Bardaweel. (2022) Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy
for the Treatment of Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry 22:18, pages 3114-3124.
Crossref
Crossref
Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, Shafina Siddiqui, Urwashi Kumar, Shreelekha Naikar, Shine Devarajan, Soumya Basu, Manash K. Paul & Jyotirmoi Aich. (2022) Drug repurposing—an emerging strategy in cancer therapeutics. Naunyn-Schmiedeberg's Archives of Pharmacology 395:10, pages 1139-1158.
Crossref
Crossref
Kai Niu, Xie-Wan Chen, Yu Qin, Lu-Ping Zhang, Rong-Xia Liao & Jian-Guo Sun. (2021) Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology 11.
Crossref
Crossref
Xiaolei Ye, Wu Zhou, Yongqi Li, Yihua Sun, Yihua Zhang, Hui Ji & Yisheng Lai. (2010) Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo. Cancer Chemotherapy and Pharmacology 66:2, pages 277-285.
Crossref
Crossref
Nir Peled, Robert L. Keith & Fred R. Hirsch. 2010. Lung Cancer. Lung Cancer
107
138
.
Seddigheh Razani-Boroujerdi & Mohan L. Sopori. (2007) Early Manifestations of NNK-Induced Lung Cancer. American Journal of Respiratory Cell and Molecular Biology 36:1, pages 13-19.
Crossref
Crossref
Claudia P. Schroeder, Humam Kadara, Dafna Lotan, Jong K. Woo, Ho-Young Lee, Waun Ki Hong & Reuben Lotan. (2006)
Involvement of Mitochondrial and Akt Signaling Pathways in Augmented Apoptosis Induced by a Combination of Low Doses of Celecoxib and
N
-(4-Hydroxyphenyl) Retinamide in Premalignant Human Bronchial Epithelial Cells
. Cancer Research 66:19, pages 9762-9770.
Crossref
Crossref
J P de Souza Filho, Z M S Correa, J C Marshall, E Anteka, A B Coutinho, M C Martins & M N BurnierJrJr. (2005) The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines. Eye 20:5, pages 598-601.
Crossref
Crossref
Thorsten Jürgen Maier, Astrid Janssen, Ronald Schmidt, Gerd Geisslinger & Sabine Grösch. (2005) Targeting the beta‐catenin/APC pathway: a novel mechanism to explain the cyclooxygenase‐2‐independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. The FASEB Journal 19:10, pages 1353-1355.
Crossref
Crossref